U.S. Hospitality Stock News

If you are wondering whether Steven Madden is attractively priced or already reflecting the good news, it helps to start with how the market has treated the stock recently and what that might imply about current expectations. The share price last closed at US$37.50, with a 7 day return of a 2.8% decline, a 30 day return of 10.3% and a 1 year return of 82.5%. Recent moves have therefore been mixed across different time frames. Over the past year, coverage has often focused on Steven Madden's...

Kodiak AI and Bosch have reached a key milestone in their collaboration on autonomous trucking hardware. Bosch is now supplying hardware components and cameras for Kodiak's autonomous SensorPods. Kodiak is validating these systems and plans to showcase the hardware at an upcoming industry expo. Kodiak AI (NasdaqGM:KDK) is moving its autonomous trucking platform closer to commercial readiness as Bosch begins delivering production grade hardware and cameras for its SensorPods. The company’s...

Avantor expanded its Masterflex fluid handling portfolio, focusing on interoperable and scalable bioprocessing solutions for life sciences customers. The company highlighted these Masterflex upgrades at INTERPHEX 2026, using the industry event to showcase operational integration and bioprocessing capabilities. These product moves come alongside leadership changes and early signs of business stabilization in certain segments. For investors watching NYSE:AVTR, the product work around...

Crystal Valley Financial (CYVF) opened 2026 with Q1 results that follow a year where trailing twelve month revenue ranged between about US$33.0 million and US$34.9 million and basic EPS sat between US$8.2 and US$9.3, alongside a net margin of 31.2% over the last 12 months. Over recent quarters the company has seen quarterly revenue run between US$7.0 million and US$9.4 million, while quarterly basic EPS moved in a band from about US$1.16 to US$2.63. This gives investors a clear read on how...

Wondering if Weyerhaeuser is quietly offering value at its current price, or if the recent share performance is a warning sign? This article breaks down what the numbers actually suggest. The stock last closed at US$23.99, with returns of a 4.2% decline over the past week, a 1.8% decline over the past month, a 0.8% gain year to date, and returns of a 5.1% decline, 11.6% decline, and 26.4% decline over the past 1, 3 and 5 years respectively. Recent attention on Weyerhaeuser has focused on how...

Olema Pharmaceuticals (NasdaqGS:OLMA) has appointed Prakash Raman, Ph.D., to its Board of Directors. Dr. Raman is an industry veteran with extensive executive and business development experience at large biopharmaceutical companies. This board change marks a fresh leadership development for Olema that had not been covered in earlier materials. For readers following Olema Pharmaceuticals, this move adds a board member with a long track record in oncology partnerships and acquisitions. The...

If you are wondering whether Badger Meter at around US$121.98 is pricing in too much optimism or leaving some value on the table, this breakdown will help you frame that question clearly. The stock has been under pressure recently, with a 0.1% return over 7 days, a 22.2% decline over 30 days, and year to date and 1 year returns of 30.8% and 46.4% declines, even though the 5 year return still sits at 37.9%. These moves have pushed Badger Meter firmly onto the radar of investors rethinking...

Investors may be wondering whether Valaris at around US$102 a share still offers value, or if most of the opportunity is already priced in. The recent share price of US$102.23 comes after returns of 12.1% over the last 7 days, 4.3% over 30 days, 96.0% year to date and 184.3% over the past year. This naturally raises questions about how much upside or risk is now built into the stock. Recent coverage has focused on Valaris as a key name in offshore drilling and contract drilling services,...

IES Holdings (IESC) has just posted another solid update, with Q1 2026 revenue at US$871 million and basic EPS of US$4.58, backed by trailing twelve month revenue of about US$3.5 billion and EPS of US$17.04. Over the past year, revenue has moved from US$3.0 billion to US$3.5 billion while EPS has risen from US$10.89 to US$17.04, reflecting a step up in earnings power that sits alongside a higher net profit margin. For investors, the key takeaway is that profitability has become more...

CNX Resources (NYSE:CNX) is expanding its Utica development and updating its long-term Marcellus plan to align with rising in-basin demand from large-scale power and data center projects. The company has completed a major refinancing of long-term notes and finalized the conversion of its remaining convertible notes, changing the structure of its balance sheet. CNX has also added to its long-dated hedging program, seeking to manage exposure to natural gas price differentials over an extended...

Alpine Banks of Colorado (ALPI.B) opened Q1 2026 earnings season with Q4 2025 revenue of US$73.3 million and basic EPS of US$1.23, supported by quarterly net income of US$19.8 million. Over the past six reported quarters, revenue has ranged from US$59.2 million to US$73.3 million while basic EPS has moved between US$0.74 and US$1.73. This gives a clear view of how the top line and EPS have tracked together across 2024 and 2025. With trailing net profit margin at 25.9% versus 21.2% a year...

Wondering whether Insmed at US$133.26 is offering fair value or stretching expectations? This article walks through how the current price stacks up against several valuation yardsticks. The stock has had a mixed run recently, with a 1.4% decline over the last 7 days, an 18.0% decline over 30 days, and a 24.8% decline year to date, set against an 84.3% return over the past year and a very large return over three years. These moves sit against a backdrop of ongoing interest in the biotech...

Applied Industrial Technologies (NYSE:AIT) announced a new share repurchase program. The authorization covers the buyback of up to 3,000,000 shares. Applied Industrial Technologies focuses on industrial distribution and related services, supplying components and solutions to a wide range of end markets. Share repurchase authorizations of this size can matter for investors who watch how companies balance cash uses between growth, acquisitions, dividends, and buybacks. For you as a...

Investors may be wondering if Ichor Holdings at around US$64.42 is still offering value, or if most of the opportunity is already priced in. The stock has seen a 33.9% gain over the last 30 days and a 215.6% return year to date, with 206.9% over the past year and 126.1% over three years. These figures can change how investors view both its potential and its risks. Recent attention on semiconductor related names, including Ichor Holdings, has highlighted themes such as supply chain...

Ares Management Q1 2026 Earnings Snapshot Ares Management (ARES) has opened 2026 earnings season with Q1 results that sit against a backdrop of trailing 12 month revenue of about US$5.6 billion and basic EPS of US$2.16, alongside net income of roughly US$468.7 million. Over the past year, revenue has stepped up from about US$3.9 billion in the period ending Q4 2024 to US$5.6 billion most recently, while basic EPS has moved from US$2.38 to US$2.16. This gives investors a clearer view of how...

Empire State Realty Trust (NYSE:ESRT) is marking the Empire State Building’s 95th anniversary with new observation deck experiences and special events. The company recently completed a US$165 million remodel aimed at improving the visitor journey and on site amenities. The building has achieved LEED v5 Platinum certification and is targeting net zero emissions for 2030, highlighting a focus on sustainability. For investors watching NYSE:ESRT, this anniversary is more than a birthday...

If you are wondering whether Guardian Pharmacy Services at US$37.37 still offers value after a strong run, the next sections will walk through what the current price could be implying. The stock has slipped 0.5% over the last 7 days and 1.6% over the last 30 days, yet it is still up 26.5% year to date and 44.9% over the past year, which may have shifted how some investors view its risk and reward trade off. Recent attention on Guardian Pharmacy Services has largely centered on its role...

Why Mechanics Bancorp (MCHB) is on investors’ radar Mechanics Bancorp (MCHB) has attracted fresh attention after recent share price moves, with the stock up about 1% over the past day but slightly lower over the past week and past 3 months. See our latest analysis for Mechanics Bancorp. While the share price has eased over the past week and quarter, the 1-year total shareholder return of 70.51% and 5-year total shareholder return of 166.71% indicate strong momentum over a longer horizon...

If you are wondering whether Carvana's current share price lines up with its underlying value, this breakdown will help you connect the recent moves in the stock to what the numbers actually say. Carvana recently closed at US$382.60, with returns of 21.9% over 30 days, a 6.5% decline over 7 days, a 4.4% decline year to date, and a 48.8% return over 1 year. The 3 year return is very large. Recent news coverage has focused on Carvana's position in online used car retailing and the market's...

Fortrea Holdings Inc., a contract research organization spun off from Labcorp in 2023, has recently reported that its sales have declined by an average 2.9% each year over the past four years, alongside returns on capital that remain below zero. This combination of contracting revenue and ineffective investment decisions suggests earlier profit pools are shrinking and raises fresh questions about the company’s ability to execute its growth plans. Against this backdrop of multi‑year sales...

If you are wondering whether Daqo New Energy's current share price reflects its true worth, it helps to start with how the market has been treating the stock lately. The shares last closed at US$19.14, with returns of a 16.7% decline over 7 days, a 9.3% decline over 30 days, and a 35.5% decline year to date, contrasted with a 48.5% gain over the past year and larger declines of 57.2% and 74.4% over 3 and 5 years. These moves have played out against a backdrop of ongoing interest in the solar...

For readers wondering whether nLIGHT's share price still reflects fair value after a major run-up, this article breaks down what the current price could imply about the business and its risks. Over the past week the stock has declined 6.3%, but it shows an 18.1% return over 30 days and an 85.0% return year to date, with the 1-year move sitting at roughly 7x. Recent coverage has focused on nLIGHT's position in the broader tech sector and how sentiment around high-growth, higher-risk names has...

Short-seller report challenges the legitimacy of Babcock & Wilcox Enterprises' purported $2.4b contract and raises concerns about undisclosed related-party links. Securities fraud class action lawsuits have been filed, alleging failures in disclosure and questioning the integrity of the company’s contract reporting. These governance and disclosure issues are drawing attention to the risks around large power generation deals and potential impact on shareholder confidence. Babcock & Wilcox...

Acadia Pharmaceuticals (NasdaqGS:ACAD) announced the planned retirement of its Head of Research and Development, Dr. Elizabeth H.Z. Thompson. Dr. Thompson is expected to transition from her current role and remain with the company as a consultant through at least the end of 2026. Her consulting role is intended to support continuity around a key Phase 2 clinical readout in Alzheimer's disease psychosis and early Phase 3 planning. Acadia focuses on central nervous system conditions, where...